Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03837509
Brief Title: INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma

First Submitted : February 7, 2019
First Submitted that Met QC Criteria : February 7, 2019
First Posted : February 12, 2019

Last Update Submitted that Met QC Criteria : May 8, 2019
Last Update Posted : May 9, 2019